FDA inspection
Nipro Pharma Corporation: FDA inspection ending Jan 30, 2024
FDA inspection 1234621 · Voluntary Action Indicated (VAI) · Odate
Key facts
| Inspection ID | 1234621 |
|---|---|
| Firm | Nipro Pharma Corporation |
| FEI number | 3017952330 |
| Address | Azamaedano 5-7, Niida, Odate Plant; Niida |
| City | Odate |
| Fiscal year | 2024 |
| Inspection end date | Jan 30, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data